Availability of Carbagen (Carbamazepine)

200mg and 400mg


Mylan UK Healthcare Ltd is the marketing authorisation holder for Carbagen (Carbamazepine) which includes Carbagen 200mg and 400mg Tablets and Carbagen 200mg and 400mg Prolonged-Release (PR) Tablets.

Latest Supply Status

Mylan are currently experiencing a temporary supply constraint of Carbagen PR 200mg and 400mg, Carbagen 200mg and Carbagen 400mg.

Normal stock levels are not anticipated to resume until the middle of 2019.

We will continue to proactively provide updates on our website regarding any changes in stock availability.

Information for Patients

Mylan is unable to make any specific treatment recommendations to patients. Patients should speak to their healthcare provider to discuss treatment options according to their health needs and their relevant clinical history.

Reporting of side effects

If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at By reporting side effects, you can help provide more information on the safety of this medicine. You should also report any side effects to Mylan UK Pharmacovigilance on +44 (0)800 121 8267 or

About Carbagen

Carbagen is indicated for the treatment of:

  • Epilepsy
    • generalised tonic-clonic
    • partial seizures
  • For the paroxysmal pain of trigeminal neuralgia.
  • For the prophylaxis of manic or hypomanic phases of manic-depressive psychosis in patients unresponsive or with contraindications to lithium therapy.


Carbagen 200mg Prolonged-Release Tablets – Patient Information Leaflet and SmPC

Carbagen 400mg Prolonged-Release Tablets – Patient Information Leaflet and SmPC

Carbagen 200mg Tablets – Patient Information Leaflet and SmPC

Carbagen 400mg Tablets – Patient Information Leaflet and SmPC

Contact Information

Mylan Medical Information team can be contacted via the Mylan switch board on +44 (0)1707 853000.